Lattice Biologic Stock Price, News & Analysis
Company Description
Lattice Biologic (OTC Link: LBLTF) is a publicly traded medical devices company in the Healthcare sector. The company has a market capitalization of $4.1M.
LBLTF stock has gained 0.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of LBLTF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Lattice Biologic (LBLTF) stock last traded at $0.0000. At a market capitalization of $4.1M, LBLTF is classified as a micro-cap stock with approximately 104.6M shares outstanding.
Latest News
Lattice Biologic has 8 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 3 with negative movement. Key topics include earnings, management. View all LBLTF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
LBLTF Company Profile & Sector Positioning
Lattice Biologic (LBLTF) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing LBLTF often look at related companies in the same sector, including Odyssey Health Inc (ODYY), Caliber Imaging & Diagnostics (LCDX), Qscreen AI Inc (PMEDF), Kelyniam Global Inc (KLYG), and Bioelectronics Corp (BIEL). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate LBLTF's relative position within its industry.